The NNSA intends to grant SHINE Technologies cost-share funding to build and operate a new facility for producing the medical isotope molybdenum-99 (Mo-99) without the use of highly-enriched uranium, according to a March 4 filing in the Federal Register.
The agency…
Morning Briefing - March 07, 2024
Visit Archives | Return to Issue PDF
Visit Archives | Return to Issue PDF
Morning Briefing
Article 7 of 7
March 07, 2024
NNSA to help fund Shine Technologies new medical isotope production facility
Partner Content
Jobs